PEAK6 Investments’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$23.1K Sell
786
-2,928
-79% -$89.3K ﹤0.01% 3189
2024
Q2
$115K Buy
+3,714
New +$118K ﹤0.01% 2981
2023
Q4
Sell
-10,198
Closed -$330K 4717
2023
Q3
$269K Buy
10,198
+9,930
+3,705% +$300K ﹤0.01% 2862
2023
Q2
$9.37K Sell
268
-1,472
-85% -$46.9K ﹤0.01% 3647
2023
Q1
$57.7K Sell
1,740
-25,134
-94% -$778K ﹤0.01% 3711
2022
Q4
$686K Buy
26,874
+22,928
+581% +$681K ﹤0.01% 2247
2022
Q3
$144K Buy
3,946
+3,678
+1,372% +$159K ﹤0.01% 3870
2022
Q2
$9.37K Buy
+268
New +$12.4K ﹤0.01% 3648
2022
Q1
Sell
-4,776
Closed -$251K 5799
2021
Q4
$245K Buy
+4,776
New +$282K ﹤0.01% 3844
2021
Q1
Sell
-28,465
Closed -$4.73M 5411
2020
Q4
$4.37M Buy
+28,465
New +$4.02M 0.01% 1168
2020
Q3
Sell
-21,619
Closed -$2.84M 4781
2020
Q2
$2.43M Buy
+21,619
New +$2.22M 0.01% 1327
2019
Q2
Sell
-1,303
Closed -$137K 4171
2019
Q1
$137K Sell
1,303
-8,576
-87% -$962K ﹤0.01% 3110
2018
Q4
$1.11M Buy
+9,879
New +$1.22M 0.01% 1678

Other funds holding PRLB

PEAK6 Investments's PRLB Position: Q3 2024 in Review

PEAK6 Investments reduced its Protolabs (PRLB) stake by 79% in Q3 2024, selling an estimated $89.3K and leaving 786 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3189.

PEAK6 Investments first reported a position in PRLB in Q4 2018 and has held it in 13 quarters since. The position peaked at $4.37M in Q4 2020. 193 funds tracked by Wall St. Rank hold PRLB as of Q3 2024.

  • PEAK6 Investments held 786 shares of Protolabs worth $23.1K as of Q3 2024.
  • PEAK6 Investments sold 2,928 Protolabs shares in Q3 2024, an estimated $89.3K.
  • Protolabs made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3189 holding.
  • PEAK6 Investments first reported a position in Protolabs in Q4 2018 and has held it in 13 quarters since.
  • PEAK6 Investments's Protolabs position peaked at $4.37M in Q4 2020.
  • 193 funds tracked by Wall St. Rank held Protolabs as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.